Similar articles

• Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.

  Brenner PF, Mishell DR Jr, Stanczyk FZ, Goebelsmann U. Brenner PF, et al. Am J Obstet Gynecol. 1977 Sep 15;129(2):133-40. doi: 10.1016/0002-9378(77)90733-5. Am J Obstet Gynecol. 1977. PMID: 900174
• Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel.

  Weiner E, Johansson ED, Wide L. Weiner E, et al. Contraception. 1976 Mar;13(3):287-98. doi: 10.1016/s0010-7824(76)80039-x. Contraception. 1976. PMID: 1248256
• Immediate postabortal insertion of a levonorgestrel-releasing IUD.

  Heikkilä M, Lähteenmäki P, Luukkainen T. Heikkilä M, et al. Contraception. 1982 Sep;26(3):245-59. doi: 10.1016/0010-7824(82)90073-7. Contraception. 1982. PMID: 6816506 No abstract available.
• Hormonal consequences of "missing the pill".

  Wang E, Shi S, Cekan SZ, Landgren BM, Diczfalusy E. Wang E, et al. Contraception. 1982 Dec;26(6):545-66. doi: 10.1016/0010-7824(82)90131-7. Contraception. 1982. PMID: 6820336 No abstract available.
• Pituitary responsiveness to luteinizing hormone-releasing hormone during treatment with subdermal D-norgestrel implants in women.

  Weiner E, Nillius SJ, Wide L, Johansson ED. Weiner E, et al. Acta Obstet Gynecol Scand Suppl. 1979;88:23-6. doi: 10.3109/00016347909157225. Acta Obstet Gynecol Scand Suppl. 1979. PMID: 393048